1. 21P Peripheral pre-existing T cell immunity as predictive biomarker in cancer immunotherapy for NSCLC patients. (December 2022) Authors: Xagara, A.; Fortis, S.; Goulielmaki, M.; Koinis, F.; Chantzara, E.; Samaras, I.; Papadopoulos, V.N.; Georgoulias, V.; Baxevanis, C.N.; Kotsakis, A. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗